→
Previous
Latest
- 2024 LEGISLATURE LRBs0276/1 MDE:cjs ASSEMBLY SUBSTITUTE AMENDMENT 1, TO ASSEMBLY BILL 932 February 8, 2024 - Offered by Representative W ITTKE.
- 2024 LEGISLATURE LRB-1082/1 MDE:skw ASSEMBLY BILL 932 January 12, 2024 - Introduced by Representatives W ITTKE, ZIMMERMAN , A RMSTRONG, M URSAU , M AXEY, OC ONNOR and J ACOBSON , cosponsored by Senators FEYEN and W ANGGAARD .
Referred to Committee on State Affairs.
andto create 238.15 (1) (f) 1m.
and to consolidate, renumber and amend 238.15 (1) (f) (intro.) and 2.
Processing or assembling products, including medical devices, pharmaceuticals, computer software or hardware, semiconductors, any other innovative technology products, or other products that are produced using manufacturing methods that are enabled by applying differentiating technology.
Processing or assembling products, including medical devices, pharmaceuticals, computer software and hardware, semiconductors, and other innovative technology products, or other products that are produced using manufacturing methods that are enabled by applying differentiating technology.
LRBs0276/1 - 2024 Legislature - 2 - MDE:cjs 2.
2.
Undertaking pre-commercialization activity related to differentiating technology that includes conducting research, developing a new product or business process, or developing a service that is principally reliant on applying differentiating technology.
Undertaking pre-commercialization activity related to differentiating technology that includes conducting research, developing a new product or business - 2024 Legislature - 2 - LRB-1082/1 MDE:skw ASSEMBLY BILL 932 process, or developing a service that is principally reliant on applying differentiating technology.
The bill replaces item 1 with the option for a business to qualify under the above criterion if the business is engaged in, or has committed to engage in, innovation, if the innovation involves the development of a differentiating technology, product, service, or production process.
The bill repeals item 1 and maintains item 2.
The bill first applies to a business initially certified for the angel investment tax credit or the early stage seed investment tax credit on the effective date of the bill.
As such, under the bill, one criterion that a business must meet for certification as a qualified new business venture is that it has the potential for increasing jobs or capital investment in Wisconsin and is undertaking pre-commercialization activity related to differentiating technology that includes conducting research, developing a new product or business process, or developing a service that is principally reliant on applying differentiating technology.
For further information see the state fiscal estimate, which will be printed as an appendix to this bill.
SECTION 1.
S ECTION 1.
238.15 (1) (f) (intro.) and 2.
of the statutes are consolidated, renumbered 238.15 (1) (f) and amended to read:
238.15 (1) (f) It has the potential for increasing jobs in this state, increasing capital investment in this state, or both, and any of the following apply:
2.
It it is undertaking pre-commercialization activity related to differentiating technology that includes conducting research, developing a new product or business process, or developing a service that is principally reliant on applying differentiating technology.
S ECTION 2.
SECTION 2.
238.15 (1) (f) 1m.
of the statutes is created to read:
238.15 (1) (f) 1m.
It is engaged in, or has committed to engage in, innovation, if the innovation involves the development of a differentiating technology, product, service, or production process.
SECTION 3.Initial applicability.
(1) This act first applies to a business that is first certified under s.
238.15 (1) on the effective date of this subsection.
⬇ Download PDF